Trial Profile
A Retrospective study on the safety and efficacy of lenalidomide in subjects with refractory/relapsed Diffuse large B cell lymphoma (DLBCL) in a real life setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 07 Sep 2016 New trial record